BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 3881374)

  • 1. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.
    Evans R; Nesbit M; Askin F; Burgert O; Cangir A; Foulkes M; Gehan E; Gilula L; Kissane J; Makley J
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):129-36. PubMed ID: 3881374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal therapy for the management of localized Ewing's sarcoma of pelvic and sacral bones: a report from the second intergroup study.
    Evans RG; Nesbit ME; Gehan EA; Garnsey LA; Burgert O; Vietti TJ; Cangir A; Tefft M; Thomas P; Askin FB
    J Clin Oncol; 1991 Jul; 9(7):1173-80. PubMed ID: 2045857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.
    Nesbit ME; Gehan EA; Burgert EO; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P; Askin FB; Kissane JM
    J Clin Oncol; 1990 Oct; 8(10):1664-74. PubMed ID: 2213103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
    Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II.
    Burgert EO; Nesbit ME; Garnsey LA; Gehan EA; Herrmann J; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P
    J Clin Oncol; 1990 Sep; 8(9):1514-24. PubMed ID: 2099751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
    Nilbert M; Saeter G; Elomaa I; Monge OR; Wiebe T; Alvegård TA
    Acta Oncol; 1998; 37(4):375-8. PubMed ID: 9743460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intergroup Ewing's Sarcoma Study: local control related to radiation dose, volume, and site of primary lesion in Ewing's sarcoma.
    Razek A; Perez CA; Tefft M; Nesbit M; Vietti T; Burgert EO; Kissane J; Pritchard DJ; Gehan EA
    Cancer; 1980 Aug; 46(3):516-21. PubMed ID: 6772293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation therapy in Ewing's sarcoma: an update of the CESS 86 trial.
    Dunst J; Jürgens H; Sauer R; Pape H; Paulussen M; Winkelmann W; Rübe C
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):919-30. PubMed ID: 7607966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive combined modality therapy including low-dose TBI in high-risk Ewing's Sarcoma Patients.
    Kinsella TJ; Glaubiger D; Diesseroth A; Makuch R; Waller B; Pizzo P; Glatstein E
    Int J Radiat Oncol Biol Phys; 1983 Dec; 9(12):1955-60. PubMed ID: 9463099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: an Intergroup Study.
    Nesbit ME; Perez CA; Tefft M; Burgert EO; Vietti TJ; Kissane J; Pritchard DJ; Gehan EA
    Natl Cancer Inst Monogr; 1981 Apr; (56):255-62. PubMed ID: 7029293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG).
    Shankar AG; Pinkerton CR; Atra A; Ashley S; Lewis I; Spooner D; Cannon S; Grimer R; Cotterill SJ; Craft AW
    Eur J Cancer; 1999 Nov; 35(12):1698-704. PubMed ID: 10674016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late follow-up of a short-term intensive regimen for Ewing's sarcoma.
    Marcus RB; Springfield DS; Graham-Pole JR; Heare TC; Enneking WF; Million RR
    Am J Clin Oncol; 1991 Oct; 14(5):446-50. PubMed ID: 1951181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
    Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H
    Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
    Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
    Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
    J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of non-metastatic Ewing's sarcoma (pelvis excluded). Results obtained in 48 cases combining local therapy (radiation and/or surgical) and adjuvant chemotherapy with vincristine, adriamycin, dactinomycin and cyclophosphamide].
    Sudanese A; Avella M; Toni A; Boriani S; Baldini N; Monesi M; Battistini A; Mancini A; Campanacci M
    Minerva Med; 1987 Apr; 78(7):473-82. PubMed ID: 3574734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of surgical margin on the prognosis of patients with Ewing's sarcoma. A report from the Cooperative Ewing's Sarcoma Study.
    Ozaki T; Hillmann A; Hoffmann C; Rübe C; Blasius S; Dunst J; Jürgens H; Winkelmann W
    Cancer; 1996 Aug; 78(4):892-900. PubMed ID: 8756387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study.
    Perez CA; Tefft M; Nesbit ME; Burgert EO; Vietti TJ; Kissane J; Pritchard DJ; Gehan EA
    Natl Cancer Inst Monogr; 1981 Apr; (56):263-71. PubMed ID: 7029294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies.
    Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R
    J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.